Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for CAMRF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
March 31, 2026 56.25M
December 31, 2025 56.34M
September 30, 2025 54.23M
June 30, 2025 58.08M
March 31, 2025 48.00M
December 31, 2024 42.86M
September 30, 2024 44.81M
June 30, 2024 47.57M
March 31, 2024 38.82M
December 31, 2023 41.16M
September 30, 2023 32.52M
June 30, 2023 36.26M
March 31, 2023 27.83M
December 31, 2022 30.00M
September 30, 2022 23.89M
June 30, 2022 23.94M
March 31, 2022 25.63M
December 31, 2021 25.73M
September 30, 2021 24.98M
June 30, 2021 26.43M
March 31, 2021 23.18M
December 31, 2020 24.92M
September 30, 2020 18.54M
June 30, 2020 18.65M
Date Value
March 31, 2020 16.13M
December 31, 2019 15.00M
September 30, 2019 15.00M
June 30, 2019 15.59M
March 31, 2019 15.33M
December 31, 2018 12.68M
September 30, 2018 11.46M
June 30, 2018 11.98M
March 31, 2018 10.39M
December 31, 2017 11.11M
September 30, 2017 10.24M
June 30, 2017 9.668M
March 31, 2017 8.224M
December 31, 2016 8.833M
September 30, 2016 6.707M
June 30, 2016 6.660M
March 31, 2016 6.790M
December 31, 2015 21.45M
September 30, 2015 12.78M
June 30, 2015 12.55M
March 31, 2015 9.127M
December 31, 2014 10.76M
September 30, 2014 5.643M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Orexo AB 25.78M
Swedencare AB 295.65M
Moberg Pharma AB 1.926M
Infant Bacterial Therapeutics AB 6.354M
Eli Lilly & Co. 85.38B

Total Liabilities (Quarterly) Related Metrics